Market capitalization | $1.56b |
Enterprise Value | $1.98b |
P/E (TTM) P/E ratio | negative |
EV/FCF (TTM) EV/FCF | 6.14 |
EV/Sales (TTM) EV/Sales | 0.76 |
P/S ratio (TTM) P/S ratio | 0.60 |
P/B ratio (TTM) P/B ratio | 1.04 |
Revenue growth (TTM) Revenue growth | 3.10% |
Revenue (TTM) Revenue | $2.61b |
As a Free StocksGuide user, you can view scores for all 6,908 stocks worldwide.
28 Analysts have issued a Teladoc Inc forecast:
28 Analysts have issued a Teladoc Inc forecast:
Jun '24 |
+/-
%
|
||
Net Profit | -1,006 -1,006 |
75%
75%
|
|
Depreciation and Amortization | 398 398 |
83%
83%
|
|
Stock Compensation | 184 184 |
12%
12%
|
|
Operating Cash Flow | 333 333 |
32%
32%
|
|
Investments | 137 137 |
23%
23%
|
|
Dividend Paid | - - |
-
|
|
Free Cash Flow | 323 323 |
36%
36%
|
In millions USD.
If you wish, we will send you an e-mail every morning with news on stocks of your portfolios.
Teladoc Health, Inc. engages in the provision of telehealthcare services using a technology platform via mobile devices, the Internet, video and phone. Its portfolio of services and solutions covers medical subspecialties from non-urgent, episodic needs like flu and upper respiratory infections, to chronic, complicated medical conditions like cancer and congestive heart failure. The company was founded on June 13, 2002 by George Byron Brooks and is headquartered in Purchase, NY.
Head office | United States |
CEO | Charles Divita |
Employees | 5,600 |
Founded | 2002 |
Website | www.teladochealth.com |
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.